Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sagent Pharmaceuticals has launched Cefazolin for injection, USP, an essential antibiotic used to treat serious infections. Sagent's Cefazolin for injection will be available in 1g single dose vials and 10g pharmacy bulk package vials.
Subscribe to our email newsletter
Sagent will begin marketing and shipping Cefazolin immediately. Cefazolin for injection, USP, is the generic equivalent of GlaxoSmithKline’s Ancef, an antibiotic used to treat bacterial infections.
Cefazolin for injection, USP, is indicated for serious infections such as those of the respiratory, biliary and urinary tracts, skin and skin structure infections, bone and joint infections, and other infections caused by various strains of streptococci.
Jeffrey Yordon, CEO, founder, and chairman of the board of Sagent, said: “This product provides our customers another sourcing option for this important antibiotic and, as with all Sagent products, offers enhanced labeling intended to optimize product safety and increase efficiency in the hospital.”